je.st
news
Home
› Xellia Enters 4 Year Collaboration To Develop New Antibiotics To Combat Multi-Drug Resistant Bacteria
Xellia Enters 4 Year Collaboration To Develop New Antibiotics To Combat Multi-Drug Resistant Bacteria
2013-02-26 05:02:00| drugdiscoveryonline Home Page
Xellia Pharmaceuticals, a fully integrated specialty pharmaceutical company focusing on the global anti-infective market, announced recently that it is developing new antibiotics effective against multi-drug resistant (MDR), Gram-negative bacteria
Tags: year
develop
collaboration
combat
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||